Among these biomarkers, steroid hormone receptors such as estrogen receptor (ER) and progesterone receptor (PR) in concert with the oncogene ErbB-2/human epidermal growth factor receptor 2 (HER-2) are critical determinants of the four main molecular subtypes of BC. This evidence concerns the gene PGR and breast cancer.